Weekly symptom app for people with advanced pancreatic or biliary cancer
Tests a weekly symptom-reporting app in adults with advanced pancreatic or biliary tract cancer.
Plain-language title generated from the registry record
Registry title: Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
Key facts
- Where
- Herlev, DenmarkSee the site
Where in Denmark
- Herlev & Gentofte University Hospital, DenmarkHerlev, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Inna Chen, MD
- Trial code
- NCT04611867
- Record updated
- 2 September 2026
- Original description
Pancreatic and biliary tract cancer are ones of the leading causes of cancer-related deaths. During the course of illness, these patients often experience marked physical suffering, psychological distress and frequent unplanned resource-demanding hospitalized care. Patients with pancreatic and lung cancer have highest rates of unplanned hospitalizations. Investigator initiated prospective "Study of Supportive Application with Integrated Patient-Reported Outcomes in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)" is to be initiated based on the great need for optimizing treatment care, reducing hospitalizations and improving outcomes.Read full original descriptionShow less
Study of Supportive Application With Integrated Patient-Reported Outcomes in Patients With Advanced Pancreatic or BiliaryTract Cancer (BetterEveryDay)
Pancreatic and biliary tract cancer are ones of the leading causes of cancer-related deaths. During the course of illness, these patients often experience marked physical suffering, psychological distress and frequent unplanned resource-demanding hospitalized care. Patients with pancreatic and lung cancer have highest rates of unplanned hospitalizations. Investigator initiated prospective "Study of Supportive Application with Integrated Patient-Reported Outcomes in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)" is to be initiated based on the great need for optimizing treatment care, reducing hospitalizations and improving outcomes.
Inclusion: Adult (aged 18 and over); Confirmed by cytology or histology advanced lung (NSCLC) or pancreatic cancer; Written informed consent before any study procedures; Planning to receive 1st line systemic anticancer therapy within ≤2 weeks; Performance status: ECOG 0-2; Access to the internet; Ability to read and respond to questions or able to complete questions with minimal assistance required from an interpreter or family member.
Exclusion: Any medical condition that the Investigator considers significant to compromise the safety of the patient or that impairs the interpretation of study assessments; No mobile device; Exhibiting signs of overt psychopathology or cognitive dysfunction; Patient participating in another interventional study during the surveillance period. This is only relevant for studies that might interfere with the intervention. Participation in protocols related only to treatment will not preclude participation in the present study. Cases of doubt will be settled by the protocol responsible.